1 Versus 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes on Treatment
1 Versus 2 Hours Post Meal Self Monitoring Blood Glucose in Gestational Diabetes Mellitus on Treatment-A Prospective Randomised Controlled Trial
1 other identifier
observational
2,954
1 country
1
Brief Summary
A study to compare between 1 and 2 hours post meal blood glucose monitoring in patients with Gestational Diabetes Mellitus requiring treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 30, 2021
CompletedFirst Submitted
Initial submission to the registry
April 6, 2022
CompletedFirst Posted
Study publicly available on registry
April 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2025
CompletedJune 12, 2025
June 1, 2025
4 years
April 6, 2022
June 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Mode of delivery
route
from point of randomization to birth of the neonate
Gestational age
in weeks
from point of randomization to birth of the neonate
Fetal weight
in gram
from point of randomization to birth of the neonate
Secondary Outcomes (2)
Maternal complications
from point of randomization to birth of the neonate
perinatal complications
from point of randomization to birth of the neonate
Study Arms (2)
1 hour
Blood glucose monitoring comprises of 1 hour post meal
2 hours
Blood glucose monitoring comprises of 2 hours post meal
Interventions
Eligibility Criteria
All women with gestational diabetes on treatment attending the antenatal clinic in our centre
You may qualify if:
- Gestational diabetes diagnosed based on National Institute for Health and Care Excellence guideline
- requiring treatment either with metformin alone or combined with insulin
You may not qualify if:
- type 1 and 2 diabetes
- bad obstetrics history
- underlying medical disorders such as Systemic Lupus Erythematosus
- fetal anomaly
- delivery elsewhere
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UKM Medical Center
Kuala Lumpur, W.Persekutuan, 56000, Malaysia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rahana Abd Rahman
National University of Malaysia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2022
First Posted
April 13, 2022
Study Start
December 30, 2021
Primary Completion
December 29, 2025
Study Completion
December 29, 2025
Last Updated
June 12, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share